IPP Bureau
Ind-Swift Laboratories PAT at Rs 18.80 cr for Q1FY22
By IPP Bureau - August 13, 2021
EPS stood at Rs 3.18
Kovai Medical Center & Hospital PAT at Rs 35.22 cr. for Q1FY22
By IPP Bureau - August 13, 2021
EPS at Rs 32.19
HCG Q1 revenue at Rs 326.58 cr. 67 per cent increase YoY
By IPP Bureau - August 13, 2021
Substantial reduction in losses
Indian pharma market grew by 13.7% in July 2021: Ind-Ra
By IPP Bureau - August 12, 2021
Demand normalisation post the second wave contributed to the steady growth
Mangalam Drugs signs tech transfer agreement with Nigerian pharma company
By IPP Bureau - August 12, 2021
Anti-malaria API facility will be operational in 15-18 months
Aster DM Healthcare PAT at Rs 44.47 crores for Q1FY22
By IPP Bureau - August 12, 2021
Income declines marginally
Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%
By IPP Bureau - August 12, 2021
It’s an AB-rated generic therapeutic version of Durezol
KK Pant is the new NPPA chairman
By IPP Bureau - August 12, 2021
It plays a pivotal role in monitoring pharmaceutical pricing
Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness
By IPP Bureau - August 12, 2021
A treatment to prevent extreme symptoms and cut hospitalisation
Research demonstrates Hoth Therapeutics HT-KIT for mast cell cancers reduces size and spread
By IPP Bureau - August 12, 2021
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm
Global cell expansion market poised for huge growth
By IPP Bureau - August 12, 2021
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
SAB Biotherapeutics nonclinical data indicates SAB-185 neutralizes Delta and Lambda SARS-CoV-2 Variants
By IPP Bureau - August 12, 2021
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee
By IPP Bureau - August 12, 2021
The company is eligible for 12 months exclusivity from launch
Low-cost flexible tactile sensors for robotics and biomedical applications developed
By IPP Bureau - August 12, 2021
The sensors have been tested for their different level of strains like micro and large scale motion monitoring and have potential applications in biomedical devices, skin electronics, and minimally invasive surgery
Natco Pharma PAT at Rs 75 crore for Q1FY22
By IPP Bureau - August 12, 2021
The company has strong product launches both in India and overseas
